Excluding HCC patients with high AFP (above 400 ng/mL), the diagnostic accuracy of each biomarker separately and their combination was moderate/good in all groups, except for their combination in BCLC‐C (AUROC = 90.5%). This evidence concerns the gene AFP and hepatocellular carcinoma.